Search

Your search keyword '"Bordini, Barbara"' showing total 532 results
Start Over Author "Bordini, Barbara"
532 results on '"Bordini, Barbara"'

1. A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcoma

Author

Aso, Ayano, Aiba, Hisaki, Traversari, Matteo, Righi, Alberto, Gambarotti, Marco, Atherley O’Meally, Ahmed, Solou, Konstantina, Cammelli, Silvia, Bordini, Barbara, Cosentino, Monica, Zuccheri, Federica, Dozza, Barbara, Frega, Giorgio, Ibrahim, Toni, Manfrini, Marco, Donati, Davide Maria, and Errani, Costantino

Published
2024
Full Text
View/download PDF

31. Single-Taper Conical Tapered Stem in Total Hip Arthroplasty for Primary Osteoarthritis: A Comparative Long-Term Registry Evaluation.

Author

Castagnini, Francesco, Bordini, Barbara, Cosentino, Monica, Gorgone, Mara, Minerba, Andrea, Rotini, Marco, Diquattro, Emanuele, and Traina, Francesco

Subjects
*TOTAL hip replacement, *PERIPROSTHETIC fractures, *SURVIVAL rate, *OSTEOARTHRITIS, *CONTROL groups
Abstract

Background/Objectives: Single-taper conical tapered stems (STCTSs) are possible options for femoral reconstruction in THA performed for primary osteoarthritis, but outcomes are poorly ascertained. A specific STCTS in THA performed for primary osteoarthritis was investigated and compared to a control group including all the other cementless stems, aiming to assess the following: (1) the survival rates of the two cohorts and the hazard ratios for failure; (2) the survival rates and the hazard ratios for failures for stem failure, stem aseptic loosening, and periprosthetic fracture. Methods: A regional arthroplasty registry study evaluating a specific STCTS in THA performed for primary osteoarthritis was designed. A control group including all the other cementless stems was considered. Results: In total, 1773 STCTSs were compared to 37,944 cementless stems. The cumulative survivorship of the STCTS cohort was 95.6% at 10 years and 92.7% at 15 years, which was not different to the control group (p = 0.252). After age stratification, the hazard ratio for STCTS failure was not different to the control group. With stem revision as the endpoint, the STCTS cohort outperformed the control group (at 10 years, 98% versus 96.8%; p < 0.001). The STCTSs achieved better survival rates in females <65 years (p = 0.023). With stem aseptic loosening as the endpoint, the survival rates did not differ between the two cohorts (p = 0.085), as well as the adjusted hazard ratios (p = 0.264). With periprosthetic fracture as the endpoint, the survival rates were better for the STCTSs (p < 0.001). Conclusions: STCTSs in THA for primary osteoarthritis provided dependable long-term outcomes, not inferior to all the other cementless stems with various designs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

32. Efficacy of Bisphosphonates in Total Hip Arthroplasty Patients: Systematic Review and Meta-Analysis.

Author

Di Martino, Alberto, Valtetsiotis, Konstantinos, Rossomando, Valentino, Brunello, Matteo, Bordini, Barbara, D'Agostino, Claudio, Ruta, Federico, Traina, Francesco, and Faldini, Cesare

Subjects
TOTAL hip replacement, BONE density, SCIENTIFIC literature, BONE resorption, DIPHOSPHONATES
Abstract

The scientific literature suggests that, if periprosthetic osteolysis (PPO) is not treated, it may have a negative impact on the results of a total hip replacement and possibly result in failure. This systematic review aimed to determine the efficacy of using bisphosphonates preventatively to limit PPO after a total hip arthroplasty (THA). Methods: A systematic review and meta-analysis were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A PICOS template was developed to ensure a structured approach. A search for relevant studies was performed across four databases, including Pubmed, Scopus, Embase, and Cochrane. They were all last searched on March 1st and were assessed using the Cochrane risk of bias tool for randomised studies. Results: The final analysis included seven studies with a total of 126 study group participants and 144 control group participants. The studies looked at Bony Mass Density in terms of bone loss on Gruen's femoral zones after THA in a bisphosphonate (treatment) and control group (placebo/no treatment). The analysis revealed a statistically significant difference (p < 0.05) in favour of the bisphosphonate group in many of the included studies at 6, 12, and 24 postoperative months. Conclusions: This systematic review and meta-analysis, using the most recent applicable studies, showed the efficacy of bisphosphonates in limiting periprosthetic osteolysis after THA in a period between 6 and 24 postoperative months. Future studies should focus increasing group sizes and collecting results beyond the 2-year mark. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

45. Long-term survival and complication rate of cementless prosthetic stems in primary total hip arthroplasty categorized by types according to Mont classification: a regional registry-based study on 53,626 implants

Author

Di Martino, Alberto, primary, Ferri, Riccardo, additional, Bordini, Barbara, additional, Brunello, Matteo, additional, Rossomando, Valentino, additional, Digennaro, Vitantonio, additional, Traina, Francesco, additional, and Faldini, Cesare, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results